Marketing-authorisation holder
Elanco Canada Limited
165 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder
165 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 165
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ADVANTAGE MULTI 1040 mg / 0.4 ml + 10 mg / 0.4 ml · Solution | Imidacloprid, Moxidectin | Canada | Marketed | 2005 |
| ADVANTAGE MULTI 100400 mg / 4.0 ml + 100 mg / 4.0 ml · Solution | Imidacloprid, Moxidectin | Canada | Marketed | 2005 |
| ADVANTAGE MULTI 1880 mg / 0.8 ml + 8 mg / 0.8 ml · Solution | Imidacloprid, Moxidectin | Canada | Marketed | 2005 |
| ADVANTAGE MULTI 20100 mg / ml + 25 mg / ml · Solution | Imidacloprid, Moxidectin | Canada | Marketed | 2005 |
| ADVANTAGE MULTI 55250 mg / 2.5 ml + 62.5 mg / 2.5 ml · Solution | Imidacloprid, Moxidectin | Canada | Marketed | 2005 |
| ADVANTAGE MULTI 940 mg / 0.4 ml + 4 mg / 0.4 ml · Solution | Imidacloprid, Moxidectin | Canada | Marketed | 2005 |
| ATOPICA25 mg · Capsule | Ciclosporin | Canada | Marketed | 2007 |
| ATOPICA100 mg · Capsule | Ciclosporin | Canada | Marketed | 2007 |
| ATOPICA10 mg · Capsule | Ciclosporin | Canada | Marketed | 2007 |
| ATOPICA50 mg · Capsule | Ciclosporin | Canada | Marketed | 2007 |
| ATOPICA FOR CATS100 mg / ml · Solution | Ciclosporin | Canada | Marketed | 2012 |
| BAYCOX50 mg / ml · Suspension | Toltrazuril | Canada | Marketed | 2010 |
| BAYTRIL150 mg · Tablet | Enrofloxacin | Canada | Marketed | 1999 |
| BAYTRIL22.7 mg · Tablet | Enrofloxacin | Canada | Not marketed | 1997 |
| BAYTRIL68 mg · Tablet | Enrofloxacin | Canada | Not marketed | 1997 |
| BAYTRIL50 mg · Tablet | Enrofloxacin | Canada | Marketed | 1999 |
| BAYTRIL15 mg · Tablet | Enrofloxacin | Canada | Marketed | 1999 |
| BAYTRIL 100100 mg / ml · Solution | Enrofloxacin | Canada | Marketed | 2004 |
| BAYTRIL INJECTION50 mg / ml · Solution | Enrofloxacin | Canada | Marketed | 1997 |
| BAYTRIL OTIC5 mg / ml + 10 mg / ml · Emulsion | Enrofloxacin, Silver sulfadiazine | Canada | Marketed | 2002 |
| BEXACAT15 mg · Tablet | Bexagliflozin | Canada | Marketed | 2026 |
| CAPSTAR57 mg · Tablet | Nitenpyram | Canada | Marketed | 2001 |
| CAPSTAR11.4 mg · Tablet | Nitenpyram | Canada | Marketed | 2001 |
| CLARO16.6 mg / ml + 2.2 mg / ml + 14.8 mg / ml · Solution | Florfenicol, Mometasone, Terbinafine | Canada | Marketed | 2019 |
| CLINACOX 0.5%5 G / Kg · Drug Premix | Diclazuril | Canada | Not marketed | 2003 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 165 | 128 | 37 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.